Sleep medicine and COVID-19. Has a new era begun?
Sleep Med
; 73: 170-176, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-654391
ABSTRACT
Since late December 2019, COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2, has spread rapidly around the world, causing unprecedented changes in provided health care services. Patients diagnosed with sleep-disordered breathing (SDB) are subject to a higher risk of worse outcomes from COVID-19, due to the high prevalence of coexistent comorbidities. Additionally, treatment with positive airway treatment devices (PAP) can be challenging because of PAP-induced droplets and aerosol. In this context, sleep medicine practices are entering a new era and need to adapt rapidly to these circumstances, so as to provide the best care for patients with SDB. Novel approaches, such as telemedicine, may play an important role in the management of patients with SDB during the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Sleep Apnea Syndromes
/
Telemedicine
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Sleep Med
Journal subject:
Neurology
/
Psychophysiology
Year:
2020
Document Type:
Article
Affiliation country:
J.sleep.2020.07.010
Similar
MEDLINE
...
LILACS
LIS